Registry of Patients Treated by Preloaded Fenestrated Stent-graft Designs for Complex Endovascular Aortic Procedures
A Physician-initiated, International, Multi-center, Retrospective and Prospective, Observational Registry of Patients Treated by Preloaded Fenestrated Stent-graft Designs for Complex Endovascular Aortic Procedures
1 other identifier
observational
741
8 countries
19
Brief Summary
The aim of the study is to evaluate the outcomes of the preloaded stent-graft design (PLD) in the routine treatment of para-renal and thoraco-abdominal aneurysms. Results and postoperative events are reported in accordance with the current reporting standards for endovascular aortic repair prepared and revised by the Ad Hoc Committee for Standardized Reporting Practices in Vascular Surgery of The Society for Vascular Surgery/American Association for Vascular Surgery. The Registry will include approximately 300 patients treated from January 2015 to May 2021 (retrospective arm) and June 2021 to June 2023 (perspective arm) for the routine treatment of para-renal and thoraco-abdominal aneurysms. To reach 300 patients, the enrollments can be extended until June 2026.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2022
Shorter than P25 for all trials
19 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2021
CompletedFirst Posted
Study publicly available on registry
December 2, 2021
CompletedStudy Start
First participant enrolled
October 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2023
CompletedMay 1, 2023
April 1, 2023
6 months
November 19, 2021
April 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical success
absence of death, type I/III endoleak, graft infection/thrombosis, aneurysm expansion and/or rupture, conversion to open repair, or new treatment-related thoraco-abdominal pathologies
30 days
Study Arms (1)
Preloaded Fenestrated Stent-graft Designs for Endovascular Aortic Procedures
Patients presenting with an acute (up to two weeks from the onset) and subacute (between 3 and 12 weeks from the onset) type B dissection with a proximal suitable non-dissected landing zone in the aortic arch or descending thoracic aorta (supra-aortic trunks debranching may be employed to obtain an adequate proximal landing zone)
Interventions
Evaluate the outcomes of the preloaded stent-graft design (PLD) in the routine treatment of para-renal and thoraco-abdominal aneurysms
Eligibility Criteria
The study will include approximately 300 patients treated from January 2015 to May 2021 (retrospective arm) and June 2021 to June 2023 (perspective arm) for the routine treatment of para-renal and thoraco-abdominal aneurysms. To reach 300 patients, the enrollments can be extended until June 2026.
You may qualify if:
- Patients presenting with an acute (up to two weeks from the onset) and subacute (between 3 and 12 weeks from the onset) type B dissection with a proximal suitable non-dissected landing zone in the aortic arch or descending thoracic aorta (supra-aortic trunks debranching may be employed to obtain an adequate proximal landing zone
You may not qualify if:
- Anatomy requiring sealing in the distal descending thoracic aorta may not be appropriate for a 50 cm sheath due to the risk of it being too short and the graft not reaching the intended landing zone;
- Celiac trunk or superior mesenteric branch design that makes the graft excessively long;
- Inability or refusal to give informed consent;
- Simultaneously participating in another investigative device or drug study;
- Frank rupture;
- Systemic infection (eg, sepsis);
- Allergy to stainless steel, polyester, solder (tin, silver), polypropylene, nitinol, or gold;
- Untreatable reaction to contrast, which, in the opinion of the investigator, cannot be adequately premedicated.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (19)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
UMass Memorial Center for Complex Aortic Disease
Worcester, Massachusetts, 01605, United States
Southwestern Medical Center, Dallas
Dallas, Texas, 75390, United States
McGovern Medical School
Houston, Texas, 77030, United States
University of Washington Seatle
Seattle, Washington, 98101, United States
Copenhagen Aortic Center
Copenhagen, Denmark
Centre Hospitalier Universitaire
Lille, France
Timone Hospital Marseille
Marseille, France
Centre Hospitalier Universitaire de Nantes
Nantes, France
Aortic Centre Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Université Paris Saclay
Paris, France
Hamburg Aortic Center
Hamburg, Germany
Ludwig Maximilian University Hospital
Munich, Germany
St. Franziskus Hospital
Münster, Germany
Policlinico S. Orsola Malpighi
Bologna, Italy
Hospital Doctor Peset
Valencia, Spain
Vascular Center Malmö, Skåne University Hospital
Malmo, Sweden
Department of Surgical Sciences, Vascular Surgery, Uppsala University
Uppsala, Sweden
University Hospitals Birmingham NHS Foundation Trust
Birmingham, United Kingdom
Kings College
London, United Kingdom
Related Publications (5)
Greenberg RK, West K, Pfaff K, Foster J, Skender D, Haulon S, Sereika J, Geiger L, Lyden SP, Clair D, Svensson L, Lytle B. Beyond the aortic bifurcation: branched endovascular grafts for thoracoabdominal and aortoiliac aneurysms. J Vasc Surg. 2006 May;43(5):879-86; discussion 886-7. doi: 10.1016/j.jvs.2005.11.063.
PMID: 16678676BACKGROUNDMohabbat W, Greenberg RK, Mastracci TM, Cury M, Morales JP, Hernandez AV. Revised duplex criteria and outcomes for renal stents and stent grafts following endovascular repair of juxtarenal and thoracoabdominal aneurysms. J Vasc Surg. 2009 Apr;49(4):827-37; discussion 837. doi: 10.1016/j.jvs.2008.11.024. Epub 2009 Feb 23.
PMID: 19233600BACKGROUNDManning BJ, Harris PL, Hartley DE, Ivancev K. Preloaded fenestrated stent-grafts for the treatment of juxtarenal aortic aneurysms. J Endovasc Ther. 2010 Aug;17(4):449-55. doi: 10.1583/10-3024.1.
PMID: 20681756BACKGROUNDKitagawa A, Greenberg RK, Eagleton MJ, Mastracci TM. Zenith p-branch standard fenestrated endovascular graft for juxtarenal abdominal aortic aneurysms. J Vasc Surg. 2013 Aug;58(2):291-300. doi: 10.1016/j.jvs.2012.12.087. Epub 2013 Apr 20.
PMID: 23611709BACKGROUNDBisdas T, Donas KP, Torsello G, Austermann M. Technical assessment of the preloaded fenestrated stent-graft in the management of pararenal aortic aneurysms. J Endovasc Ther. 2013 Aug;20(4):461-8. doi: 10.1583/13-4310.1.
PMID: 23914852BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof
Study Record Dates
First Submitted
November 19, 2021
First Posted
December 2, 2021
Study Start
October 30, 2022
Primary Completion
April 20, 2023
Study Completion
April 20, 2023
Last Updated
May 1, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share